Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 361-370 of 640 total displayed.

Past content (since Jan 1999):

Scientific Contributions
Clonidine Improves Spontaneous Baroreflex Sensitivity in Conscious Mice Through Parasympathetic Activation
Jens Tank, Jens Jordan, André Diedrich, Michael Obst, Ralph Plehm, Friedrich C. Luft, and Volkmar Gross
Hypertension published March 29, 2004, doi:10.1161/01.HYP.0000125884.49812.72 [Abstract]  

Scientific Contributions
Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors
Yuichiro Ishiyama, Patricia E. Gallagher, David B. Averill, E. Ann Tallant, K. Bridget Brosnihan, and Carlos M. Ferrario
Hypertension published March 8, 2004, doi:10.1161/01.HYP.0000124667.34652.1a [Abstract]  

Scientific Contributions
Effects of Indapamide, a Thiazide-Like Diuretic, on Structure of Cerebral Arterioles in Hypertensive Rats
Jean-Marc Chillon and Gary L. Baumbach
Hypertension published March 8, 2004, doi:10.1161/01.HYP.0000122874.21730.81 [Abstract]  

Scientific Contributions
ETA Receptor Mediates Altered Leukocyte-Endothelial Cell Interaction and Adhesion Molecules Expression in DOCA-Salt Rats
Glaucia E. Callera, Augusto C. Montezano, Rhian M. Touyz, Telma M.T. Zorn, Maria Helena C. Carvalho, Zuleica B. Fortes, Dorothy Nigro, Ernesto L. Schiffrin, and Rita C. Tostes
Hypertension published March 1, 2004, doi:10.1161/01.HYP.0000117296.30296.14 [Abstract]  

Hypertension Grand Rounds
Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone: Theory and Therapy
Theodore L. Goodfriend and David A. Calhoun
Hypertension 2004;43:518-524; published online before print as doi:10.1161/01.HYP.0000116223.97436.e5 [Abstract] [Full text]  

Scientific Contributions
Sympathetic Responses to Stress and Rilmenidine in 2K1C Rabbits: Evidence of Enhanced Nonvascular Effector Mechanism
Geoffrey A. Head and Sandra L. Burke
Hypertension 2004;43:636-642; published online before print as doi:10.1161/01.HYP.0000116301.02975.aa [Abstract] [Full text]  

Scientific Contributions
AT1 Receptor Blocker Added to ACE Inhibitor Provides Benefits at Advanced Stage of Hypertensive Diastolic Heart Failure
Junichi Yoshida, Kazuhiro Yamamoto, Toshiaki Mano, Yasushi Sakata, Nagahiro Nishikawa, Mayu Nishio, Tomohito Ohtani, Takeshi Miwa, Masatsugu Hori, and Tohru Masuyama
Hypertension 2004;43:686-691; published online before print as doi:10.1161/01.HYP.0000118017.02160.fa [Abstract] [Full text]  

Scientific Contributions
Endothelin-1 Promotes Ca2+ Antagonist-Insensitive Coronary Smooth Muscle Contraction Via Activation of {epsilon}-Protein Kinase C
Lashonn L. McNair, Daisy A. Salamanca, and Raouf A. Khalil
Hypertension published February 23, 2004, doi:10.1161/01.HYP.0000118520.92686.3b [Abstract]  

Scientific Contributions
Effect of Reduced Angiotensin-Converting Enzyme Gene Expression and Angiotensin-Converting Enzyme Inhibition on Angiotensin and Bradykinin Peptide Levels in Mice
Duncan J. Campbell, Theodora Alexiou, Hong D. Xiao, Sebastien Fuchs, Michael J. McKinley, Pierre Corvol, and Kenneth E. Bernstein
Hypertension published February 9, 2004, doi:10.1161/01.HYP.0000119190.06968.f1 [Abstract]  

Scientific Contributions
AT1 Receptor Blocker Added to ACE Inhibitor Provides Benefits at Advanced Stage of Hypertensive Diastolic Heart Failure
Junichi Yoshida, Kazuhiro Yamamoto, Toshiaki Mano, Yasushi Sakata, Nagahiro Nishikawa, Mayu Nishio, Tomohito Ohtani, Takeshi Miwa, Masatsugu Hori, and Tohru Masuyama
Hypertension published February 2, 2004, doi:10.1161/01.HYP.0000118017.02160.fa [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment